MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 53 filers reported holding MERSANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,678 | -63.7% | 98,959 | -6.1% | 0.00% | – |
| Q2 2023 | $346,588 | -19.3% | 105,346 | +0.8% | 0.00% | -100.0% |
| Q1 2023 | $429,622 | -29.8% | 104,531 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $612,212 | -11.5% | 104,473 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $692,000 | +47.2% | 102,344 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $470,000 | +46.4% | 101,735 | +26.6% | 0.00% | – |
| Q1 2022 | $321,000 | -40.9% | 80,349 | -7.9% | 0.00% | -100.0% |
| Q4 2021 | $543,000 | -31.2% | 87,246 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $789,000 | -38.8% | 83,710 | -11.8% | 0.00% | -50.0% |
| Q2 2021 | $1,289,000 | -0.8% | 94,917 | +18.2% | 0.00% | 0.0% |
| Q1 2021 | $1,299,000 | -39.4% | 80,270 | -0.4% | 0.00% | -33.3% |
| Q4 2020 | $2,144,000 | -30.7% | 80,560 | -51.5% | 0.00% | -40.0% |
| Q3 2020 | $3,092,000 | +91.1% | 166,060 | +140.1% | 0.01% | +66.7% |
| Q2 2020 | $1,618,000 | +396.3% | 69,156 | +23.6% | 0.00% | +200.0% |
| Q1 2020 | $326,000 | +2.8% | 55,932 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $317,000 | +264.4% | 55,293 | 0.0% | 0.00% | – |
| Q3 2019 | $87,000 | -61.2% | 55,293 | 0.0% | 0.00% | – |
| Q2 2019 | $224,000 | +124.0% | 55,293 | +190.1% | 0.00% | – |
| Q1 2019 | $100,000 | +28.2% | 19,058 | 0.0% | 0.00% | – |
| Q4 2018 | $78,000 | -59.2% | 19,058 | 0.0% | 0.00% | – |
| Q3 2018 | $191,000 | -43.8% | 19,058 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $340,000 | +26.4% | 19,058 | +11.9% | 0.00% | 0.0% |
| Q1 2018 | $269,000 | +99.3% | 17,035 | +107.7% | 0.00% | – |
| Q4 2017 | $135,000 | -4.9% | 8,200 | 0.0% | 0.00% | – |
| Q3 2017 | $142,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |